Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Vivus Llc

Clinical trials sponsored by Vivus Llc, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New chemo formula could cut side effects in lymphoma transplants Results expected Mar 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet recruiting 1

New hope for PAH patients: Extended-Release tacrolimus enters phase 3 trial

Disease control Not yet recruiting

This Phase 3 study tests VI-0106, an extended-release form of tacrolimus, in 300 people with pulmonary arterial hypertension (PAH) who still have trouble with daily activities despite taking standard PAH medications. Participants will receive either the drug or a placebo for 24 w…

Phase 3 • Sponsor: VIVUS LLC • Aim: Disease control

Last updated Jun 27, 2026 13:00 UTC